231 related articles for article (PubMed ID: 15364128)
1. Human small cell lung cancer cells express functional VEGF receptors, VEGFR-2 and VEGFR-3.
Tanno S; Ohsaki Y; Nakanishi K; Toyoshima E; Kikuchi K
Lung Cancer; 2004 Oct; 46(1):11-9. PubMed ID: 15364128
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia-induced epithelial VEGF-C/VEGFR-3 upregulation in carcinoma cell lines.
Simiantonaki N; Jayasinghe C; Michel-Schmidt R; Peters K; Hermanns MI; Kirkpatrick CJ
Int J Oncol; 2008 Mar; 32(3):585-92. PubMed ID: 18292935
[TBL] [Abstract][Full Text] [Related]
3. Interactions between sphingosine-1-phosphate and vascular endothelial growth factor signalling in ML-1 follicular thyroid carcinoma cells.
Balthasar S; Bergelin N; Löf C; Vainio M; Andersson S; Törnquist K
Endocr Relat Cancer; 2008 Jun; 15(2):521-34. PubMed ID: 18509004
[TBL] [Abstract][Full Text] [Related]
4. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
[TBL] [Abstract][Full Text] [Related]
5. c-MET mutational analysis in small cell lung cancer: novel juxtamembrane domain mutations regulating cytoskeletal functions.
Ma PC; Kijima T; Maulik G; Fox EA; Sattler M; Griffin JD; Johnson BE; Salgia R
Cancer Res; 2003 Oct; 63(19):6272-81. PubMed ID: 14559814
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor receptor-1 promotes migration and invasion in pancreatic carcinoma cell lines.
Wey JS; Fan F; Gray MJ; Bauer TW; McCarty MF; Somcio R; Liu W; Evans DB; Wu Y; Hicklin DJ; Ellis LM
Cancer; 2005 Jul; 104(2):427-38. PubMed ID: 15952180
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor-C and its receptor VEGFR-3 in non-small-cell lung cancer: concurrent expression in cancer cells from primary tumour and metastatic lymph node.
Saintigny P; Kambouchner M; Ly M; Gomes N; Sainte-Catherine O; Vassy R; Czernichow S; Letoumelin P; Breau JL; Bernaudin JF; Kraemer M
Lung Cancer; 2007 Nov; 58(2):205-13. PubMed ID: 17686546
[TBL] [Abstract][Full Text] [Related]
8. The multi-targeted kinase inhibitor SU5416 inhibits small cell lung cancer growth and angiogenesis, in part by blocking Kit-mediated VEGF expression.
Litz J; Sakuntala Warshamana-Greene G; Sulanke G; Lipson KE; Krystal GW
Lung Cancer; 2004 Dec; 46(3):283-91. PubMed ID: 15541812
[TBL] [Abstract][Full Text] [Related]
9. Increased expressions of vascular endothelial growth factor (VEGF), VEGF-C and VEGF receptor-3 in prostate cancer tissue are associated with tumor progression.
Yang J; Wu HF; Qian LX; Zhang W; Hua LX; Yu ML; Wang Z; Xu ZQ; Sui YG; Wang XR
Asian J Androl; 2006 Mar; 8(2):169-75. PubMed ID: 16491267
[TBL] [Abstract][Full Text] [Related]
10. Expression of VEGFR-2 on HaCaT cells is regulated by VEGF and plays an active role in mediating VEGF induced effects.
Yang XH; Man XY; Cai SQ; Yao YG; Bu ZY; Zheng M
Biochem Biophys Res Commun; 2006 Oct; 349(1):31-8. PubMed ID: 16930552
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of vascular endothelial growth factor-C and vascular endothelial growth factor receptor 3 in patients with T1 lung adenocarcinoma.
Kojima H; Shijubo N; Yamada G; Ichimiya S; Abe S; Satoh M; Sato N
Cancer; 2005 Oct; 104(8):1668-77. PubMed ID: 16116610
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factors synthesized by human lung mast cells exert angiogenic effects.
Detoraki A; Staiano RI; Granata F; Giannattasio G; Prevete N; de Paulis A; Ribatti D; Genovese A; Triggiani M; Marone G
J Allergy Clin Immunol; 2009 May; 123(5):1142-9, 1149.e1-5. PubMed ID: 19275959
[TBL] [Abstract][Full Text] [Related]
13. [Autocrine stimulation of receptor-tyrosine kinases (RTK) in human tumor cell lines in vitro: therapeutic implications].
Gaumann A; Groot M; Drexler HC; Breier G
Verh Dtsch Ges Pathol; 2003; 87():232-9. PubMed ID: 16888917
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor C stimulates progression of human gastric cancer via both autocrine and paracrine mechanisms.
Kodama M; Kitadai Y; Tanaka M; Kuwai T; Tanaka S; Oue N; Yasui W; Chayama K
Clin Cancer Res; 2008 Nov; 14(22):7205-14. PubMed ID: 19010837
[TBL] [Abstract][Full Text] [Related]
15. Expression of vascular endothelial growth factor receptors on tumor cells in head and neck squamous cell carcinoma.
Lalla RV; Boisoneau DS; Spiro JD; Kreutzer DL
Arch Otolaryngol Head Neck Surg; 2003 Aug; 129(8):882-8. PubMed ID: 12925349
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of the expression of vascular endothelial growth factors A, B, C, and D and their receptors R1, R2, and R3 in patients with nonsmall cell lung cancer.
Carrillo de Santa Pau E; Arias FC; Caso Peláez E; Muñoz Molina GM; Sánchez Hernández I; Muguruza Trueba I; Moreno Balsalobre R; Sacristán López S; Gómez Pinillos A; del Val Toledo Lobo M
Cancer; 2009 Apr; 115(8):1701-12. PubMed ID: 19197998
[TBL] [Abstract][Full Text] [Related]
17. Autocrine vascular endothelial growth factor signalling in breast cancer. Evidence from cell lines and primary breast cancer cultures in vitro.
Weigand M; Hantel P; Kreienberg R; Waltenberger J
Angiogenesis; 2005; 8(3):197-204. PubMed ID: 16328160
[TBL] [Abstract][Full Text] [Related]
18. The balance of VEGF-C and VEGFR-3 mRNA is a predictor of lymph node metastasis in non-small cell lung cancer.
Takizawa H; Kondo K; Fujino H; Kenzaki K; Miyoshi T; Sakiyama S; Tangoku A
Br J Cancer; 2006 Jul; 95(1):75-9. PubMed ID: 16755294
[TBL] [Abstract][Full Text] [Related]
19. Expression of the vascular endothelial growth factor receptor-3 (VEGFR-3) and its ligand VEGF-C in human colorectal adenocarcinoma.
Witte D; Thomas A; Ali N; Carlson N; Younes M
Anticancer Res; 2002; 22(3):1463-6. PubMed ID: 12168824
[TBL] [Abstract][Full Text] [Related]
20. Expression of vascular endothelial growth factor-C and its receptor in osteosarcomas.
Park HR; Min K; Kim HS; Jung WW; Park YK
Pathol Res Pract; 2008; 204(8):575-82. PubMed ID: 18440723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]